In vitro identification of novel acetylcholinesterase reactivators

References

• Aardema H, Meertens JH, Ligtenberg JJ, et al. (2008). Organophosphorus pesticide poisoning: cases and developments. Neth J Med. 66:149–153.
   PubMed Web of Science ®Google Scholar
• Acharya J, Gupta AK, Dubey DK, et al. (2009). Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase. Eur J Med Chem. 44:1335–1340.
   PubMed Web of Science ®Google Scholar
• Acharya J, Gupta AK, Mazumder A, et al. (2009). In-vitro regeneration of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing xylene linker. Eur J Med Chem. 44:1326–1330.
   PubMed Web of Science ®Google Scholar
• Antonijevic B, Stojiljkovic MP. (2007). Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res. 5:71–82.
   PubMedGoogle Scholar
• Bajgar J. (2004). Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem. 38:151–216.
   PubMed Web of Science ®Google Scholar
• Bajgar J, Kuca K, Fusek J, et al. (2007). Inhibition of blood cholinesterases following intoxication with VX and its derivatives. J Appl Toxicol. 27:458–463.
   PubMed Web of Science ®Google Scholar
• Cabal J, Kuca K, Jun D, et al. (In press.) Structure-activity relationship of nerve agents. In Bajgar J. Central and Peripheral Nervous System: Effects of Highly Toxic Organophosphates and Their Antidotes. Signpost.
   Google Scholar
• da Silva AP, Farina M, Franco JL, et al. (2008). Temporal effects of newly developed oximes (K027, K048) on malathion-induced acetylcholinesterase inhibition and lipid peroxidation in mouse prefrontal cortex. Neurotoxicol. 29:184–189.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney DK, Andres V, et al. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• Gyenge M, Kalasz H, Petroianu GA, et al. (2007). Measurement of K-27, an oxime-type cholinesterase reactivator by high-performance liquid chromatography with electrochemical detection from different biological samples. J Chromatogr A. 1161:146–151.
   PubMed Web of Science ®Google Scholar
• Jokanovic M, MaksimovićM. (1995). A comparison of trimedoxime, obidoxime, pralidoxime and HI-6 in the treatment of oral organophosphorus insecticide poisoning in the rat. Arch Toxicol. 70: 119–123.
   PubMed Web of Science ®Google Scholar
• Lucic Vrdoljak A, Calic M, Radic B, et al. (2006). Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology. 228:41–50.
   Google Scholar
• Lundy PM, Raveh L, Amitai G. (2006). Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev. 25:231–243.
   PubMedGoogle Scholar
• Kassa J, Karasova J, Musilek K, et al. (2008). An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology. 243:311–316.
   PubMed Web of Science ®Google Scholar
• Kassa J, Kuca K, Karasova J, et al. (2008). The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Mini Rev Med Chem. 8:1134–1143.
   PubMed Web of Science ®Google Scholar
• Kovarik Z, Lucic Vrdoljak A, Berend S, et al. (2009). Evaluation of oxime K203 as antidote in tabun poisoning. Arch Industr Hyg Toxicol. 60:19–26.
   Google Scholar
• Kuca K, Bielavsky J, Cabal J, et al. (2003). Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 44:3123–3125.
   Web of Science ®Google Scholar
• Kuca K, Cabal J, Patocka J, et al. (2004). Synthesis of bisquaternary symmetric – χ,δ-bis(2-hydroxyiminomethylpyridinium)alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett Org Chem. 1:84–86.
   Web of Science ®Google Scholar
• Kuca K, Jun D, Bajgar J. (2007a). Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem Toxicol. 30:31–40.
   PubMed Web of Science ®Google Scholar
• Kuca K, Jun D, Bajgar J. (2007b). Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications. Curr Pharm Des. 13: 3445–3452.
   PubMedGoogle Scholar
• Kuca K, Jun D, Musilek K. (2006). Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem. 6:269–277.
   PubMed Web of Science ®Google Scholar
• Kuca K, Kassa J. (2003). A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enzyme Inhib Med Chem. 18:529–535.
   PubMed Web of Science ®Google Scholar
• Kuca K, Kassa J. (2004). In vitro reactivation of acetylcholinesterase using the oxime K027. Vet Hum Toxicol. 46:15–18.
   PubMedGoogle Scholar
• Kuca K, Musilek K, Jun D, et al. (2009). Novel oximes. In: Gupta RC. Handbook of Toxicology of Chemical Warfare Agents. London: Elsevier, 997–1021.
   Google Scholar
• Marrs TC, Maynard RL, Sidell FR. (1996). Chemical Warfare Agents: Toxicology and Treatment. Chicester: J. Wiley and Sons.
   Google Scholar
• Marrs TC, Rice P, Vale JA. (2006). The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev. 25:297–323.
   PubMedGoogle Scholar
• Musilek K, Holas O, Kuca K, et al. (2007a). Novel series of bispyridinium compounds bearing a (Z)-but-2-ene Linker – Synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Biorg Med Chem Lett. 17:3172–3176.
   PubMed Web of Science ®Google Scholar
• Musilek K, Holas O, Kuca K, et al. (2007b). Synthesis of the novel series of asymmetrical bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem. 22:425–432.
   PubMed Web of Science ®Google Scholar
• Musilek K, Jun D, Cabal J, et al. (2007c). Design of a potent reactivator of tabun-inhibited acetylcholinesterase—Synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J Med Chem. 50: 5514–5518.
   PubMed Web of Science ®Google Scholar
• Musilek K, Lipka L, Racakova V, et al. (2006). New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem Papers. 60:48–51.
   Web of Science ®Google Scholar
• Oh KA, Park NJ, Park NS, et al. (2008). Determination of reactivation potency for DFP- and paraoxon-inhibited acetylcholinesterase by pyridinium oximes. Chem Biol Interact. 175:365–367.
   PubMed Web of Science ®Google Scholar
• Oh KA, Yang GY, Jun D, et al. (2006). Bis-pyridium aldoxime reactivators connected with CH2O(CH2)nOCH2 linkers between pyridinium rings and their reactivity against VX. Biorg Med Chem Lett. 16:4852–4855.
   PubMed Web of Science ®Google Scholar
• Ohta H, Ohmori T, Suzuki S, et al. (2006). New safe method for preparation of sarin-exposed human erythrocytes acetylcholinesterase using non-toxic and stable sarin analogue isopropyl p-nitrophenyl methylphosphonate and its application to evaluation of nerve agent antidotes. Pharmaceut Res. 23:2827–2833.
   Google Scholar
• Patocka J, Cabal J, Kuca K., et al. (2005). Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus esters: In vitro kinetics and thermodynamics. J Appl Biomed. 2:91–99.
   Google Scholar
• Petroianu GA, Arafat K, Nurulain SM, et al. (2007). In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon. J Appl Toxicol. 27:168–175.
   PubMed Web of Science ®Google Scholar
• Petroianu GA, Nurulain SM, Nagelkerke N, et al. (2006). Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. J Appl Toxicol. 26:262–268.
   PubMed Web of Science ®Google Scholar
• Picha J, Kuca K, Kivala M, et al. (2005). New group of monoquaternary reactivators of the acetylcholinesterase inhibited by nerve agents. J Enzyme Inhib Med Chem. 20:233–237.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Jun D, Kuca K. (2008). Photometric microplate assay for estimation of the efficacy of paraoxon-inhibited acetylcholinesterase reactivation. J Enzyme Inhib Med Chem. 23:781–784.
   PubMed Web of Science ®Google Scholar
• Sakurada K, Ikegaya H, Ohta H, et al. (2006). Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM). Toxicol Lett. 166:255–260.
   PubMedGoogle Scholar
• Shih TM, Rowland TC, McDonough JH. (2007). Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine. J Pharmacol Exp Ther. 320:154–161.
   PubMed Web of Science ®Google Scholar
• Sinko G, Calic M, Kovarik Z. (2006). Para- and ortho-pyridinium aldoximes in reaction with acetylthiocholine. FEBS Lett. 580:3167–3172.
   Google Scholar
• Taysse L, Daulon S, Delamanche S, et al. (2006). Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig. Toxicology. 225:25–35.
   PubMed Web of Science ®Google Scholar
• Tekes K, Hasan MY, Sheen R, et al. (2006). High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator. J Chromatogr A. 1122:84–87.
   PubMed Web of Science ®Google Scholar
• Weerasekera G, Smith KD, Needham LL, et al. (2008). A rapid, cost-effective method for analyzing organophosphorus pesticide metabolites in human urine for counter-terrorism response. J Anal Toxicol. 32:106–115.
   Google Scholar
• Worek F, Widmann R, Knopff O, et al. (1998). Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol. 72:237–243.
   PubMed Web of Science ®Google Scholar